The Valley Desk

NCT01200992 · Interventional trial

Efficacy and Safety Evaluation of EN3348 (Mycobacterial Cell Wall-DNA Complex [MCC]) as Compared With Mitomycin C in the Intravesical Treatment of Subjects With BCG Recurrent/Refractory Non-muscle Invasive Bladder Cancer

Overall registry status Terminated

Phase 3

Conditions Bladder Neoplasm, Carcinoma in Situ, Mycobacterium, Neoplasm Recurrence, Local, Transitional Cell, Carcinoma

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov